Portugal is using the global stage at Expo 2025 in Osaka to highlight its growing life sciences sector, including advances in biotechnology, pharmaceuticals and digital health.
The country’s exhibition, part of its wider presence at the international fair, is designed to attract foreign investment and partnerships. Organisers say the focus is on presenting Portugal not only as a hub for research but also as a competitive environment for manufacturing and commercialisation.
Industry delegates from Portugal have been holding meetings with potential partners in Asia and beyond. The aim is to secure collaborations that could strengthen the country’s capacity for drug discovery, precision medicine and health technology innovation.
Analysts note that Portugal’s life sciences industry has expanded steadily in recent years, helped by research institutions, start-ups and established firms working in areas such as oncology, infectious diseases and agricultural biotechnology.
Expo 2025, which opened earlier this year in Osaka, is expected to draw millions of visitors and thousands of companies from around the world. Portugal’s participation comes at a time when governments are increasingly seeking to position their science and technology sectors in global supply chains.
Officials believe the exposure could help Portuguese companies reach new markets and boost exports, particularly in high-value areas like biologics manufacturing and genomics. The exhibition is also being used to promote the country’s academic expertise and growing number of innovation hubs.